⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IRON News
Disc Medicine, Inc. Common Stock
Form 8-K
sec.gov
IRON
Disc Medicine Announces Pricing of $450 Million Upsized Public Offering of Common Stock
globenewswire.com
IRON
A Phase 3 Win and a 130% Takeover Premium Lit Up Rare Blood-Disease Stocks on Monday
prnewswire.com
AGIO
KROS
PTGX
IRON
SLN
Disc Medicine Announces Proposed $350 Million Public Offering of Common Stock and Pre-Funded Warrants
globenewswire.com
IRON
Form 8-K
sec.gov
IRON
Disc Medicine Announces Success on All Primary and Secondary Endpoints in the Pivotal Phase 3 APOLLO Trial of Bitopertin in Adults and Adolescents with Erythropoietic Protoporphyria (EPP)
globenewswire.com
IRON
Disc Medicine to Host Corporate Webcast to Discuss Topline Results from the APOLLO Phase 3 Trial of Bitopertin in Erythropoietic Protoporphyria (EPP)
globenewswire.com
IRON
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
globenewswire.com
IRON
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
prnewswire.com
IRON
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
globenewswire.com
IRON